Gemcitabine confirmed as the first-line therapy for pancreatic cancer

被引：3
|
作者：
Claire Greenhill
机构：
来源：
Nature Reviews Gastroenterology & Hepatology | 2011年 / 8卷 / 1期
关键词：
D O I：
10.1038/nrgastro.2010.200
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [41] The First-Line Treatment for Advanced Pancreatic Cancer
    Merl, Man Yee
    Li, Jia
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2010, 11 (02): : 148 - 150
  • [42] Marimastat as first-line therapy for patients with unresectable pancreatic cancer: A randomized trial
    Bramhall, SR
    Rosemurgy, A
    Brown, PD
    Bowry, C
    Buckels, JAC
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (15) : 3447 - 3455
  • [43] Vinorelbine and cisplatin combined with endostatin as the first-line therapy for metastatic pancreatic cancer
    Dong-Min Chang
    Journal of Pharmaceutical Analysis, 2010, 22 (01) : 69 - 71
  • [44] Vinorelbine and cisplatin combined with endostatin as the first-line therapy for metastatic pancreatic cancer
    DongMin ChangCan ZhouYong ZhangDeQiang ChenGang MaFeng Cao Department of Surgical Oncologythe First Affiliated HospitalMedical School of Xian Jiaotong UniversityXian China
    Academic Journal of Xi'an Jiaotong University, 2010, 22 (01) : 69 - 71
  • [45] Danish experiences with FOLFIRINOX as first-line therapy in patients with inoperable pancreatic cancer
    Kraemer, Pia Charlotte
    Schmidt, Hjordis Hjalting
    Ladekarl, Morten
    DANISH MEDICAL JOURNAL, 2014, 61 (04):
  • [46] Paclitaxel/carboplatin/gemcitabine as first-line treatment of ovarian cancer
    Hansen, SW
    Geertsen, F
    Stroyer, I
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 96 - 96
  • [47] A confirmed first-line option for CLL
    Rebecca Kirk
    Nature Reviews Clinical Oncology, 2011, 8 (5) : 253 - 253
  • [48] Gemcitabine and S-1 as first-line chemotherapy in patients with metastatic or advanced pancreatic cancer.
    Fang, Weijia
    Zhao, Peng
    Zheng, Yi
    Jiang, Weiqin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [49] Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study
    Kyung Hee Lee
    Min Kyoung Kim
    Yeol Hong Kim
    Baek Yeol Ryoo
    Ho Yeong Lim
    Hong Suk Song
    Hoon Kyo Kim
    Myung Ah Lee
    Seock Ah Im
    Heung Moon Chang
    Jae Yong Cho
    Dae Young Zang
    Bong Seog Kim
    Jun Suk Kim
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 317 - 325
  • [50] Updated results of biweekly gemcitabine/nab-paclitaxel as first-line treatment for advanced pancreatic cancer
    Kokkali, S.
    Drizou, M.
    Tripodaki, E.
    Stefanou, D.
    Magou, E.
    Zylis, D.
    Kapiris, M.
    Nasi, D.
    Georganta, C.
    Ardavanis, A.
    ANNALS OF ONCOLOGY, 2018, 29
12345